A Study of SHR-A1811 in Subjects With Gynaecologic Oncology

Real-world Study of Serplulimab in 2L and Above Treatment of Cervical Cancer

NCT05883670 ·Status: RECRUITING

A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies

NCT05990803 ·Status: RECRUITING ·Phase: PHASE2

Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

NCT04886700 ·Status: UNKNOWN ·Phase: PHASE2

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

NCT06226350 ·Status: COMPLETED ·Phase: PHASE2

A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma

NCT04814108 ·Status: COMPLETED ·Phase: PHASE2

A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma

NCT05668858 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies

NCT05342506 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

NCT06237257 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

NCT05105672 ·Status: UNKNOWN ·Phase: PHASE2

AK105 Combined With Anlotinib in Patients With Cervical Cancer

NCT05137171 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer

NCT07059221 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study of SCB01A in Patient With Head and Neck Cancer

NCT02488629 ·Status: TERMINATED ·Phase: PHASE2

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

NCT03614949 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

NCT05179239 ·Status: TERMINATED ·Phase: PHASE3

Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer

NCT06241781 ·Status: RECRUITING ·Phase: PHASE2

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

NCT04906993 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy of Chemotherapy Alone in Patients With Poor-differentiated Early-stage Cervical Cancer

NCT05863377 ·Status: UNKNOWN

A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT00358930 ·Status: COMPLETED ·Phase: PHASE2

Donafenib for Recurrent Cervical Cancer

NCT05310331 ·Status: UNKNOWN ·Phase: PHASE2

Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT00865098 ·Status: COMPLETED ·Phase: PHASE2

Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer

NCT05838729 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

NCT06011291 ·Status: RECRUITING ·Phase: PHASE1

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT04128696 ·Status: TERMINATED ·Phase: PHASE3

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

NCT06895369 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

NCT03020823 ·Status: TERMINATED ·Phase: PHASE2